Guang-Shun Yang
Overview
Explore the profile of Guang-Shun Yang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
1904
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pang S, Sun Z, Lu W, Si-Ma H, Lin Z, Shi Y, et al.
Cancer Manag Res
. 2022 Mar;
14:969-980.
PMID: 35283645
Background: s function in hepatocellular carcinoma (HCC) has rarely been addressed. We intend to explore the prognostic significance and therapeutic meaning of in HCC in this study. Methods: Multiple common...
2.
Yu W, Yu G, Dong H, Chen K, Xie J, Yu H, et al.
J Gastroenterol
. 2020 Oct;
55(12):1171-1182.
PMID: 33089343
Background: Intrahepatic cholangiocarcinoma (ICC) is the second most common tumor in primary liver cancer, but the prognostic factors associated with long-term outcomes after surgical resection remain poorly defined. This study...
3.
Feng Y, Xiao F, Yang N, Zhu N, Fu Y, Zhang H, et al.
Int J Clin Exp Pathol
. 2020 Jan;
10(7):7873-7881.
PMID: 31966635
Hepatocellular carcinoma (HCC) is a common malignant tumor lacking sensitive biomarkers for prognosis. Sox3, a member of the Sex determining region Y box gene superfamily, has been demonstrated to be...
4.
Ye Q, Pang S, Yang N, Zhang H, Fu Y, Lin B, et al.
J Gastrointest Surg
. 2019 Jun;
23(8):1549-1558.
PMID: 31197690
Background: We aim to investigate the safety and efficacy of radiofrequency ablation in the treatment of solitary hepatocellular carcinoma (3-5 cm) in comparison with surgical resection. Methods: Included in this...
5.
Liang Y, Feng Y, Zong M, Wei X, Lee J, Feng Y, et al.
Hepatology
. 2017 Nov;
67(5):1807-1822.
PMID: 29152756
Conclusion: These data argue that while dominantly activating mutants of β-catenin are oncogenic, inhibiting the oncogenic signaling pathway generates a pro-oncogenic microenvironment that may facilitate HCC recurrence following a targeted...
6.
Shen Y, He H, Shi Y, Cao J, Yuan J, Wang Z, et al.
Mol Carcinog
. 2016 Aug;
56(2):751-760.
PMID: 27478926
Krüppel-like factor 8 (KLF8) is highly expressed in hepatocellular carcinoma (HCC) and contributes to tumor initiation and progression by promoting HCC cell proliferation and invasion. However, the role of KLF8...
7.
Wu Z, Wu X, Zhu N, Xu Z, Li W, Zhang H, et al.
World J Gastroenterol
. 2015 Jan;
21(3):935-43.
PMID: 25624728
Aim: To investigate the prognostic factors after resection for hepatitis B virus (HBV)-associated intrahepatic cholangiocarcinoma (ICC) and to assess the impact of different extents of lymphadenectomy on patient survival. Methods:...
8.
Cai W, Lin J, He G, Wang H, Lu J, Yang G
Int J Clin Exp Pathol
. 2015 Jan;
7(11):7890-8.
PMID: 25550829
To investigate the appropriate cutoff point of CA19-9 for prognosis and other potential prognostic factors that may affect survival of patients with hilar cholangiocarcinoma (HC) after radical surgery. 168 patients...
9.
Yang T, Song B, Zhang J, Yang G, Zhang H, Yu W, et al.
Gut
. 2014 Nov;
65(1):124-33.
PMID: 25398772
Objective: STK33 has been reported to play an important role in cancer cell proliferation. We investigated the role of STK33 in hepatocellular carcinoma (HCC) and its underlying mechanisms. Design: 251...
10.
Wu Z, Xu Z, Li W, Zhang H, Yang N, Yao X, et al.
J Surg Res
. 2014 Aug;
193(1):153-60.
PMID: 25128925
Background: To investigate the clinicopathologic characteristics of patients with both hepatitis B virus-surface antigen and hepatitis C virus antibody negative hepatocellular carcinoma (non-B non-C HCC [NBNC-HCC]) and examine the impact...